Korsana Biosciences, Inc

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Sep 1813GPassive stake of 5% or more (13G), filed by General Atlantic
2. Sep 1613GPassive stake of 5% or more (13G), filed by Wellington Biomedical Innovation Master Investors (Cayman) II
3. Sep 1513DStake of 5% or more (13D), filed by Venrock Healthcare Capital Partners III
4. Sep 1113DStake of 5% or more (13D), filed by Fairmount Funds Management
5. Sep 118-KMaterial agreement and acquisition or sale of assets completed1.012.012.023.023.035.015.025.035.055.067.019.01
6. Aug 278-KOther events and shareholder vote5.078.019.01
7. Aug 258-KOther events8.01
8. Aug 1513GPassive stake of 5% or more (13G), filed by ADAR1 Capital Management
9. Aug 1413GPassive stake of 5% or more (13G), filed by Balyasny Asset Management
10. Aug 410-QQuarterly report
11. Jul 24424B3Prospectus for an offering
12. May 1210-QQuarterly report
13. Apr 18-KMaterial agreement and officer or director change1.015.015.027.019.01
14. Mar 3010-KAnnual report
15. Feb 178-KRegulation FD disclosure7.019.01
16. Jan 68-KMaterial agreement and Regulation FD disclosure1.017.019.01
17. Dec 1, 20258-KOther events8.01
18. Nov 12, 202510-QQuarterly report
19. Sep 23, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
20. Aug 5, 202510-QQuarterly report
21. Jun 18, 20258-KShareholder vote5.079.01
22. May 7, 20258-KMaterial agreement1.019.01
23. May 7, 2025424B5Prospectus for an offering
24. May 6, 2025S-3Shelf registration
25. May 6, 202510-QQuarterly report
26. Mar 25, 20258-KMaterial agreement and unregistered sale of shares1.013.029.01
27. Mar 4, 202510-KAnnual report
28. Feb 4, 2025S-3Shelf registration
29. Dec 17, 20248-KMaterial agreement and Regulation FD disclosure1.017.019.01
30. Nov 14, 202410-QQuarterly report